Kurt G. Conti serves as Executive at Edge Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Kurt G. Conti has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 23, 2018 involved transacting 58,476 shares valued at $0.
Kurt G. Conti currently holds 160,810 shares of Edge Therapeutics, Inc. (EDGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kurt G. Conti has been a net neutral trader of EDGE stock. They have purchased $0 and sold $0 worth of shares.
Kurt G. Conti's most recent insider trade was on Mar 23, 2018, when they sold 58,476 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 6, 2015 | EDGE | $0 | Conversion | 29,238 | $N/A | Discretionary |
| Oct 6, 2015 | EDGE | $0 | Conversion | 163,731 | $N/A | Discretionary |
| Oct 6, 2015 | EDGE | $0 | Conversion | 14,619 | $N/A | Discretionary |
| Oct 6, 2015 | EDGE | $0 | Conversion | 789,420 | $N/A | Discretionary |
| Oct 6, 2015 | EDGE | $0 | Conversion | 14,619 | $N/A | Discretionary |